Cargando…
Letter in response to the case report “Topical ruxolitinib in the treatment of refractory facial seborrheic dermatitis”
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10684363/ https://www.ncbi.nlm.nih.gov/pubmed/38034367 http://dx.doi.org/10.1016/j.jdcr.2023.09.038 |
| _version_ | 1785151385877086208 |
|---|---|
| author | Teklu, Meron Chung, Hye Jin |
| author_facet | Teklu, Meron Chung, Hye Jin |
| author_sort | Teklu, Meron |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10684363 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-106843632023-11-30 Letter in response to the case report “Topical ruxolitinib in the treatment of refractory facial seborrheic dermatitis” Teklu, Meron Chung, Hye Jin JAAD Case Rep Notes & Comments Elsevier 2023-10-15 /pmc/articles/PMC10684363/ /pubmed/38034367 http://dx.doi.org/10.1016/j.jdcr.2023.09.038 Text en © 2023 by the American Academy of Dermatology, Inc. Published by Elsevier Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
| spellingShingle | Notes & Comments Teklu, Meron Chung, Hye Jin Letter in response to the case report “Topical ruxolitinib in the treatment of refractory facial seborrheic dermatitis” |
| title | Letter in response to the case report “Topical ruxolitinib in the treatment of refractory facial seborrheic dermatitis” |
| title_full | Letter in response to the case report “Topical ruxolitinib in the treatment of refractory facial seborrheic dermatitis” |
| title_fullStr | Letter in response to the case report “Topical ruxolitinib in the treatment of refractory facial seborrheic dermatitis” |
| title_full_unstemmed | Letter in response to the case report “Topical ruxolitinib in the treatment of refractory facial seborrheic dermatitis” |
| title_short | Letter in response to the case report “Topical ruxolitinib in the treatment of refractory facial seborrheic dermatitis” |
| title_sort | letter in response to the case report “topical ruxolitinib in the treatment of refractory facial seborrheic dermatitis” |
| topic | Notes & Comments |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10684363/ https://www.ncbi.nlm.nih.gov/pubmed/38034367 http://dx.doi.org/10.1016/j.jdcr.2023.09.038 |
| work_keys_str_mv | AT teklumeron letterinresponsetothecasereporttopicalruxolitinibinthetreatmentofrefractoryfacialseborrheicdermatitis AT chunghyejin letterinresponsetothecasereporttopicalruxolitinibinthetreatmentofrefractoryfacialseborrheicdermatitis |